SCHEMBL25096247

SCHEMBL25096247

Cc1cn2cc(NC(=O)c3ccc(N4CCNC(C)(C)C4)c4ccnnc34)cc(F)c2n1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CTNNB1 P35222 1/20 0.39
▸ TCF7L2 Q9NQB0 1/20 0.39
▸ PTK6 Q13882 3/20 0.35
▸ IRAK4 Q9NWZ3 2/20 0.34
▸ LATS1 O95835 1/20 0.34
▸ AURKB Q96GD4 5/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ FGFR3 P22607 3/20 0.32
▸ CSF1R P07333 2/20 0.31
▸ FGFR1 P11362 2/20 0.31
▸ FGFR2 P21802 2/20 0.31
▸ FGFR4 P22455 1/20 0.31
▸ AURKA O14965 3/20 0.31
▸ FLT3 P36888 3/20 0.31
▸ PRKCQ Q04759 1/20 0.31
▸ HTT P42858 1/20 0.30
▸ RPS6KB1 P23443 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30312602 0.99 CTNNB1 (0.39) CTNNB1TCF7L2PTK6IRAK4LATS1
SCHEMBL25097176 0.92 PTK6 (0.34) CTNNB1TCF7L2PTK6IRAK4AURKB
Hydrochloric Acid SCHEMBL30312636 0.92 LCK (0.34) CTNNB1TCF7L2PTK6IRAK4AURKB
SCHEMBL25097181 0.91 HTR1A (0.31) CTNNB1TCF7L2IRAK4
SCHEMBL25096256 0.89 PTK6 (0.36) CTNNB1TCF7L2PTK6AURKB
SCHEMBL30217847 0.88 FGFR3 (0.40) CTNNB1TCF7L2PTK6IRAK4LATS1
SCHEMBL25097072 0.88 FGFR3 (0.40) CTNNB1TCF7L2PTK6IRAK4LATS1
SCHEMBL25095792 0.87 KIF18A (0.33) —
SCHEMBL26769278 0.87 IRAK4 (0.41) CTNNB1TCF7L2PTK6IRAK4LATS1
SCHEMBL30312601 0.87 MAPK1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023034811-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2023-03-09 — — WO disclosed
Send feedback